Osaic Holdings’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98K Sell
280
-235
-46% -$1.66K ﹤0.01% 7050
2025
Q4
$2.55K Sell
515
-220
-30% -$927 ﹤0.01% 6997
2025
Q3
$3.26K Buy
735
+220
+43% +$749 ﹤0.01% 6964
2025
Q2
$1.61K Buy
515
+115
+29% +$324 ﹤0.01% 7011
2025
Q1
$1K Sell
400
-115
-22% -$361 ﹤0.01% 6814
2024
Q4
$1.6K Hold
515
﹤0.01% 6697
2024
Q3
$1.23K Hold
515
﹤0.01% 6776
2024
Q2
$1.3K Buy
+515
New +$1.31K ﹤0.01% 6741

Other funds holding DRTS

Osaic Holdings's DRTS Position: Q1 2026 in Review

Osaic Holdings reduced its Alpha Tau Medical (DRTS) stake by 46% in Q1 2026, selling an estimated $1.66K and leaving 280 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #7050.

Osaic Holdings first reported a position in DRTS in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.26K in Q3 2025. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Osaic Holdings held 280 shares of Alpha Tau Medical worth $1.98K as of Q1 2026.
  • Osaic Holdings sold 235 Alpha Tau Medical shares in Q1 2026, an estimated $1.66K.
  • Alpha Tau Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7050 holding.
  • Osaic Holdings first reported a position in Alpha Tau Medical in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Alpha Tau Medical position peaked at $3.26K in Q3 2025.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.